A Lower HCC Incidence in Chronic HBV-Infected Patients Recovered from Acute-on-Chronic Liver Failure: A Prospective

Jianhua Yin1, Xiang Xu2,3, Rui Pu1

  • 1Department of Epidemiology, Second Military Medical University, Shanghai, China.

Journal of Oncology
|November 7, 2022
PubMed

Insights

A hepatitis B virus-acute-on-chronic liver failure (HBV-ACLF) episode may decrease hepatocellular carcinoma (HCC) risk in patients with chronic liver disease. This study developed a nomogram to predict HCC occurrence in these patients.

Area of Science:

  • Hepatology
  • Oncology
  • Virology

Background:

  • Chronic hepatitis B virus (HBV) infection activation can lead to acute-on-chronic liver failure (ACLF).
  • The impact of HBV-ACLF episodes on hepatocellular carcinoma (HCC) development is not well understood.

Purpose of the Study:

  • To investigate the effect of HBV-ACLF episodes on the incidence of HCC.
  • To identify risk factors for HCC development in patients with chronic HBV infection.
  • To develop a predictive model for HCC occurrence in HBV-related liver disease.

Main Methods:

  • Prospective cohort study involving 769 HBV-ACLF patients and 2114 HBV-related chronic liver disease (HBV-CLD) patients.
  • Propensity score matching was used to balance baseline characteristics between cohorts.
  • Multivariate Cox regression analysis and nomogram construction were employed to assess HCC risk and predict outcomes.

Main Results:

  • The cumulative incidence of HCC was significantly lower in the HBV-ACLF cohort compared to the HBV-CLD cohort (5.77/1000 vs. 9.78/1000 person-years).
  • HBV-ACLF episodes independently reduced HCC risk, irrespective of liver cirrhosis or family history of HCC.
  • Older age, male sex, liver cirrhosis, and low platelet count were identified as independent risk factors for HCC.
  • A nomogram demonstrated good predictive accuracy for 3-year HCC probability (AUC = 0.812).

Conclusions:

  • An episode of HBV-ACLF is associated with a decreased risk of developing HCC in patients with chronic HBV infection.
  • Older age and liver cirrhosis are significant independent predictors of HCC occurrence.
  • The developed nomogram provides a reliable tool for predicting HCC risk in patients with HBV-related liver disease.
Abstract